-+ 0.00%
-+ 0.00%
-+ 0.00%

NXERA PHARMA ENTERS INTO EXCLUSIVE LICENSE, SUPPLY AND COMMERCIALIZATION AGREEMENT WITH SYNMOSA FOR QUVIVIQ® (DARIDOREXANT) ACROSS EIGHT ASIA-PACIFIC MARKETS

Reuters·10/14/2026 07:54:06

Please log in to view news